These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26783066)

  • 1. Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells.
    Fang Y; Zhang Q; Wang X; Yang X; Wang X; Huang Z; Jiao Y; Wang J
    Int J Oncol; 2016 Mar; 48(3):1016-28. PubMed ID: 26783066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells.
    Chimplee S; Roytrakul S; Sukrong S; Srisawat T; Graidist P; Kanokwiroon K
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
    Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
    Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
    Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
    Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
    Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
    Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.
    Raman V; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
    Int J Oncol; 2017 Dec; 51(6):1801-1808. PubMed ID: 29075784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways.
    Wu YM; Chen ZJ; Jiang GM; Zhang KS; Liu Q; Liang SW; Zhou Y; Huang HB; Du J; Wang HS
    Oncotarget; 2016 Mar; 7(11):12568-81. PubMed ID: 26871469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenocystine-induced cell apoptosis and S-phase arrest inhibit human triple-negative breast cancer cell proliferation.
    Long M; Wu J; Hao J; Liu W; Tang Y; Li X; Su H; Qiu W
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1077-84. PubMed ID: 26194802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.
    Gangapuram M; Jean R; Mazzio E; Badisa R; Eyunni S; Goodman CB; Redda KK; Soliman KF
    Anticancer Res; 2016 Oct; 36(10):5043-5052. PubMed ID: 27798863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and MEK Blockade in Triple Negative Breast Cancer Cells.
    Maiello MR; D'Alessio A; Bevilacqua S; Gallo M; Normanno N; De Luca A
    J Cell Biochem; 2015 Dec; 116(12):2778-85. PubMed ID: 25959272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
    Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
    Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells.
    Zafar A; Singh S; Satija YK; Saluja D; Naseem I
    Toxicol In Vitro; 2018 Feb; 46():19-28. PubMed ID: 28986287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chalcone-based molecule, BDP inhibits MDA‑MB‑231 triple-negative breast cancer cell growth by suppressing Hsp90 function.
    Oh YJ; Seo YH
    Oncol Rep; 2017 Oct; 38(4):2343-2350. PubMed ID: 28849241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.
    Zou M; Li Y; Xia S; Chu Q; Xiao X; Qiu H; Chen Y; Zheng Z; Liu F; Zhuang L; Yu S
    Cell Physiol Biochem; 2017; 44(2):778-791. PubMed ID: 29169152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein enhances the radiosensitivity of breast cancer cells via G₂/M cell cycle arrest and apoptosis.
    Liu X; Sun C; Jin X; Li P; Ye F; Zhao T; Gong L; Li Q
    Molecules; 2013 Oct; 18(11):13200-17. PubMed ID: 24284485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel inhibitor of triple-negative breast cancer cell growth by screening of a small-molecule library.
    Fujita T; Mizukami T; Okawara T; Inoue K; Fujimori M
    Breast Cancer; 2014 Nov; 21(6):738-47. PubMed ID: 23456737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.